Radiation Therapy Oncology Group: Glioblastoma trials
The registry lists 11 Glioblastoma studies with Radiation Therapy Oncology Group as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 3Phase 2 8Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent GlioblastomaCompletedNCT01730950Phase 2Results posted
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT01062399Phase 1/2Results posted
- Veliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaCompletedNCT01026493Phase 1/2Results posted
- Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaCompletedNCT00304031Phase 3Results posted
- Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeTerminatedNCT00006916Phase 2Results posted
- Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant GliomaCompletedNCT03722355Phase 3
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00099125Phase 2
- Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00006388Phase 2
- Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma MultiformeCompletedNCT00006386Phase 2
- Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma MultiformeCompletedNCT00003417Phase 1/2
- Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeCompletedNCT00002545Phase 3